CoChat

Danazol for pelvic pain associated with endometriosis

Selak, V, Farquhar, C, Prentice, A, Singla, A · 2001 · Cochrane Database of Systematic Reviews
Cited by 85

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Endometriosis is defined as the presence of endometrial tissue (stromal and glandular) outside the normal uterine cavity. Conventional medical and surgical treatments for endometriosis aim to remove or decrease deposits of ectopic endometrium. The observation that hyperandrogenic states (an excess of male hormone) induce atrophy of the endometrium has led to the use of androgens in the treatment of endometriosis. Danazol is one of these treatments used. The efficacy of danazol is based on its ability to produce a high androgen/low estrogen environment (a pseudo menopause) which results in the atrophy of endometriotic implants and thus an improvement in painful symptoms. OBJECTIVES: To determine the effectiveness of danazol compared to placebo or no treatment in the treatment of the symptoms and signs, other than infertility, of endometriosis in women of reproductive age. SEARCH STRATEGY: The Menstrual Disorders Group search strategy was used to identify randomised controlled trials of the use of danazol in endometriosis. In addition, all reference lists of included trials were searched, and relevant drug companies were contacted for details of unpublished trials SELECTION CRITERIA: Randomised controlled trials in which danazol (alone or as adjunctive therapy) was compared to placebo or no therapy. Trials which only reported infertility outcomes were excluded. DATA COLLECTION AND ANALYSIS: Only four trials met the inclusion criteria and two authors extracted data independently from these trials. All four trials compared danazol to placebo. Two trials used danazol as sole therapy and two trials used danazol as an adjunct to surgery. Although the main outcome was pain improvement other data relating to laparoscopic scores and hormonal parameters were also collected. MAIN RESULTS: Treatment with danazol (including adjunctive surgical therapy) was effective in relieving painful symptoms related to endometriosis when compared to placebo. Laparoscopic scores were improved with danazol treatment (including adjunctive therapy) when compared with either placebo or no treatment. Side effects were more commonly reported in those patients receiving danazol than placebo. REVIEWER'S CONCLUSIONS: Danazol is effective in treating the symptoms and signs of endometriosis. However, its use is limited by the occurrence of androgenic side effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd000068

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 14

  1. Kauppila, 1988, Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery, Fertility & Sterility, 49, 37, 10.1016/S0015-0282(16)59644-7 · DOI
  2. Telimaa, 1987, Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery, Gynecological Endocrinology, 1, 363, 10.3109/09513598709082709 · DOI · Paper page
  3. Telimaa, 1990, Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate, European Journal of Obstetrics Gynecology and Reproductive Biology, 36, 97, 10.1016/0028-2243(90)90055-6 · DOI
  4. Bayer, 1988, Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study, Journal of Reproductive Medicine, 33, 179
  5. Mamood, 1990, The impact of treatment on the natural history of endometriosis, Human Reproduction, 5, 965, 10.1093/oxfordjournals.humrep.a137229 · DOI · Paper page
  6. Seibel, 1982, The effectiveness of danazol on subsequent fertility in minimal endometriosis, Fertility & Sterility, 38, 534, 10.1016/S0015-0282(16)46630-6 · DOI
  7. Telimaa, 1988, Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis, Fertility & Sterility, 50, 872, 10.1016/S0015-0282(16)60364-3 · DOI
  8. 1979, Classification of endometriosis, Fertility & Sterility, 32, 633, 10.1016/S0015-0282(16)44409-2 · DOI · Paper page
  9. Barbieri, 1977, Danazol inhibits steroidogenesis, Fertility & Sterility, 28, 809, 10.1016/S0015-0282(16)42732-9 · DOI
  10. Barbieri, 1990, Endometriosis 1990 - current treatment approaches, Drugs, 39, 502, 10.2165/00003495-199039040-00003 · DOI
  11. Hughes, 2003, Ovulation suppression for endometriosis (Cochrane Review), The Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000155 · DOI · Paper page
  12. McLaren, 1996, New aspects of pathogenesis of endometriosis, Current Obstetrics & Gynaecology, 6, 85, 10.1016/S0957-5847(96)80021-7 · DOI
  13. Prentice, 1999, Gonadotrophin-releasing hormone analogues for pain associated with endometriosis, The Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000346.pub2 · DOI · Paper page
  14. Rock, 1992, Pathogenesis of endometriosis, Lancet, 340, 1264, 10.1016/0140-6736(92)92959-J · DOI

Metadata

Authors
Selak, V, Farquhar, C., Prentice, A., & Singla, A.
Venue
Cochrane Database of Systematic Reviews
Published
2001-10-23
Issue
2
Pages
CD000068-CD000068
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4242983679
Cited by
85
References
3
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Danazol for pelvic pain associated with endometriosis. https://app.cochat.ai/papers/10.1002/14651858.cd000068
The paper
Selak, V, Farquhar, C., Prentice, A., & Singla, A. (2001). Danazol for pelvic pain associated with endometriosis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000068

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.